StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Pharma-Bio Serv's operating income for the twelve months ending Jul 31, 2026 was -$154.94K. For fiscal 2025 it was -$637.66K. The highest annual figure on record is $6.07M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Oct 31, 2025-$637.66K–
FY2024Oct 31, 2024-$1.29M-215.2%
FY2023Oct 31, 2023$1.12M-4.9%
FY2022Oct 31, 2022$1.17M–
FY2021Oct 31, 2021-$3.85M-273.2%
FY2020Oct 31, 2020$2.23M+31.2%
FY2019Oct 31, 2019$1.70M–
FY2018Oct 31, 2018-$1.26M–
FY2017Oct 31, 2017-$777.82K–
FY2016Oct 31, 2016-$91.76K-105.2%
FY2015Oct 31, 2015$1.78M-37.8%
FY2014Oct 31, 2014$2.86M-52.8%
FY2013Oct 31, 2013$6.07M+5.9%
FY2012Oct 31, 2012$5.73M+66.1%
FY2011Oct 31, 2011$3.45M+466.0%
FY2010Oct 31, 2010$609.89K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026-$71.81K–
Q2 FY2026CQ1 2026Apr 30, 2026$144.68K–
Q1 FY2026CQ4 2025Jan 31, 2026-$94.54K–
Q4 FY2025CQ3 2025Oct 31, 2025-$133.27K–
Q3 FY2025CQ2 2025Jul 31, 2025-$313.88K–
Q2 FY2025CQ1 2025Apr 30, 2025-$98.32K–
Q1 FY2025CQ4 2024Jan 31, 2025-$92.19K–
Q4 FY2024CQ3 2024Oct 31, 2024-$154.13K–
Q3 FY2024CQ2 2024Jul 31, 2024-$381.78K-182.9%
Q2 FY2024CQ1 2024Apr 30, 2024-$313.38K-182.5%
Q1 FY2024CQ4 2023Jan 31, 2024-$438.30K-233.4%
Q4 FY2023CQ3 2023Oct 31, 2023-$51.77K-105.1%
Q3 FY2023CQ2 2023Jul 31, 2023$460.47K–
Q2 FY2023CQ1 2023Apr 30, 2023$380.08K–
Q1 FY2023CQ4 2022Jan 31, 2023$328.63K-8.8%
Q1 FY2022CQ4 2021Jul 31, 2022$1.01M+279.9%
Q2 FY2022CQ1 2022Apr 30, 2022-$369.51K-215.8%
Q4 FY2021CQ3 2021Oct 31, 2021-$4.80M-3262.6%
Q3 FY2021CQ2 2021Jul 31, 2021$360.49K-55.9%
Q2 FY2021CQ1 2021Apr 30, 2021$264.78K-63.2%
Q1 FY2021CQ4 2020Jan 31, 2021$319.12K-40.5%
Q4 FY2020CQ3 2020Oct 31, 2020$151.71K-64.4%
Q3 FY2020CQ2 2020Jul 31, 2020$816.69K+126.4%
Q2 FY2020CQ1 2020Apr 30, 2020$720.38K+51.0%
Q1 FY2020CQ4 2019Jan 31, 2020$536.76K+14.0%
Q4 FY2019CQ3 2019Oct 31, 2019$426.56K-14.2%
Q3 FY2019CQ2 2019Jul 31, 2019$360.70K-50.0%
Q2 FY2019CQ1 2019Apr 30, 2019$476.93K–
Q1 FY2019CQ4 2018Jan 31, 2019$471.02K–
Q4 FY2018CQ3 2018Oct 31, 2018$497.44K+298.0%
Q3 FY2018CQ2 2018Jul 31, 2018$721.82K–
Q2 FY2018CQ1 2018Apr 30, 2018-$8.68K–
Q1 FY2018CQ4 2017Jan 31, 2018-$2.47M–
Q4 FY2017CQ3 2017Oct 31, 2017$125.00K–
Q3 FY2017CQ2 2017Jul 31, 2017-$194.25K–
Q2 FY2017CQ1 2017Apr 30, 2017-$324.57K–
Q1 FY2017CQ4 2016Jan 31, 2017-$384.00K–
Q4 FY2016CQ3 2016Oct 31, 2016-$449.76K–
Q3 FY2016CQ2 2016Jul 31, 2016-$120.79K–

More Pharma-Bio Serv figures

See a number that looks wrong?